Story perspectives

Trump Administration Final Rule Cuts Medicaid Gender-Affirming Care

8/24/2026

Summary

Story summary

President Donald Trump’s administration issued a final rule denying Medicaid coverage for pediatric gender-affirming medication.
The rule also prohibits Children’s Health Insurance Program (CHIP) funding for gender-affirming surgery for children.
The rule will take effect on Oct. 13, 2026.
Medicaid experts warn the rule could set a precedent for denying other FDA-approved drugs.
Medicaid normally must cover most FDA-approved outpatient drugs for medically accepted uses.

1 of 1

Story summary

President Donald Trump’s administration issued a final rule denying Medicaid coverage for pediatric gender-affirming medication.
The rule also prohibits Children’s Health Insurance Program (CHIP) funding for gender-affirming surgery for children.
The rule will take effect on Oct. 13, 2026.
Medicaid experts warn the rule could set a precedent for denying other FDA-approved drugs.
Medicaid normally must cover most FDA-approved outpatient drugs for medically accepted uses.